Kidney Stones (Nephrolithiasis)
Summary
Kidney stones (nephrolithiasis) affect 10-15% of the population over a lifetime. Calcium oxalate stones are most common (70-80%). Presentation is typically severe, colicky loin-to-groin pain with haematuria. CT KUB (non-contrast) is the gold standard investigation. Most small stones (<5mm) pass spontaneously with conservative management. Larger stones or complications require intervention (shockwave lithotripsy, ureteroscopy, or PCNL). An infected obstructed kidney is a urological emergency requiring immediate decompression (nephrostomy/stent) and antibiotics.
Key Facts
- Lifetime Risk: 10-15% (recurrence 50% at 5 years)
- Stone Types: Calcium oxalate (70-80%), Uric acid (10%), Struvite (10%), Cystine (1%)
- Classic Pain: Loin to groin, colicky, severe ("worst pain ever")
- Diagnosis: CT KUB (non-contrast) - 98% sensitivity
- Management: Most <5mm pass; >10mm usually require intervention
- EMERGENCY: Fever + stone = infected obstruction = immediate drainage
Clinical Pearls
"Fever + Stone = EMERGENCY": An infected obstructed kidney can rapidly lead to sepsis and death. These patients need emergency decompression (nephrostomy or stent), not just antibiotics.
"Pain Severity ≠ Stone Size": A 3mm stone can cause excruciating pain while a staghorn calculus may be painless. Pain relates to ureteric distension, not stone size.
"Tamsulosin Helps Expulsion": Medical expulsive therapy with tamsulosin increases spontaneous passage rates for distal ureteric stones 5-10mm.
"Stone Analysis is Gold": Every first-time stone should be analysed. Composition guides dietary and medical prevention strategies.
Why This Matters Clinically
Renal colic is one of the most common presentations to ED. Distinguishing uncomplicated colic (manageable conservatively) from infected obstruction (emergency) is critical.
Incidence
- Lifetime risk: 10-15%
- Incidence increasing globally (dietary factors)
- Peak age: 30-60 years
Demographics
- M:F = 3:1 (gap narrowing)
- White > Black > Asian
- Higher in hot climates, summer months
Risk Factors
| Modifiable | Non-Modifiable |
|---|---|
| Low fluid intake | Male sex |
| High sodium diet | Family history |
| High oxalate/purine diet | Ethnicity |
| Obesity | Anatomical abnormalities |
| Chronic dehydration |
Stone Types
| Type | Frequency | pH | Radiopacity | Associations |
|---|---|---|---|---|
| Calcium Oxalate | 70-80% | Any | Radio-opaque | Hypercalciuria, hyperoxaluria |
| Calcium Phosphate | 10-15% | Alkaline | Radio-opaque | RTA, hyperparathyroidism |
| Uric Acid | 10% | Acidic (<5.5) | Radiolucent | Gout, high purine diet |
| Struvite | 5-10% | Alkaline | Radio-opaque | Infection (Proteus, Klebsiella) |
| Cystine | 1-2% | Acidic | Slightly opaque | Cystinuria (genetic) |
Stone Formation
- Supersaturation: Urine becomes supersaturated with stone-forming substances
- Crystal nucleation: Crystals begin to form
- Crystal aggregation: Crystals clump together
- Crystal retention: Aggregate adheres to urothelium
- Stone growth: Progressive accretion
Factors Promoting Stone Formation
- Low urine volume (concentrated urine)
- High urinary excretion of calcium, oxalate, uric acid
- Low citrate (citrate inhibits stone formation)
- Urinary stasis (anatomical abnormalities)
- Infection (struvite stones)
Pain Mechanism
- Stone obstructs ureter
- Urine backs up → Pelvis distends
- Prostaglandins released → Smooth muscle spasm
- → Intense, colicky pain
Symptoms
| Feature | Description |
|---|---|
| Pain | Severe, colicky, loin to groin radiation, waves |
| Nausea/Vomiting | Very common, due to shared vagal innervation |
| Haematuria | 85-90% (micro or macro) |
| Dysuria/Frequency | If stone in distal ureter/VUJ |
| Restlessness | Unable to find comfortable position (vs peritonitis = still) |
Pain Location by Stone Position
| Stone Location | Pain Pattern |
|---|---|
| Upper ureter | Loin pain, radiates to groin |
| Mid ureter | Radiates to lower abdomen |
| Lower ureter/VUJ | Radiates to genitalia, dysuria |
Signs
Signs of Infected Obstruction (EMERGENCY)
General
- Patient in severe pain, writhing, unable to settle
- Fever (suggests infection)
- Signs of dehydration
Abdominal Examination
- Renal angle tenderness
- May be normal between pain waves
- Usually soft abdomen (vs peritonitis = rigid)
Differential Diagnosis
| Condition | Distinguishing Features |
|---|---|
| Ruptured AAA | Older, vascular history, pulsatile mass |
| Appendicitis | RIF pain, peritonism, fever |
| Ectopic pregnancy | Female, missed period, bleeding |
| Ovarian torsion | Female, sudden onset, adnexal tenderness |
| Pyelonephritis | Fever prominent, pyuria, bacteriuria |
| Diverticulitis | LIF pain, fever, altered bowels |
First-Line
| Test | Purpose | Notes |
|---|---|---|
| Urinalysis | Blood, infection | Haematuria in 85-90% |
| MSU | Culture if infection suspected | |
| Bloods | FBC, U&E, CRP, Calcium | Check for AKI, sepsis |
| CT KUB | Gold standard imaging | 98% sensitivity, no contrast needed |
CT KUB Findings
- Stone visualisation (even small stones)
- "Rim sign" around impacted stone
- Hydronephrosis
- Perinephric stranding
- Stone size and location
Other Imaging
- USS: First-line in pregnancy, children; detects hydronephrosis, not all stones
- KUB X-ray: Limited sensitivity; misses radiolucent stones
Metabolic Workup (Recurrent Stones)
- 24-hour urine collection: Calcium, oxalate, uric acid, citrate, creatinine, volume
- Serum: Calcium, phosphate, PTH, uric acid
- Stone analysis: Essential for first stone
Emergency - Infected Obstructed Kidney
┌──────────────────────────────────────────────────────────┐
│ FEVER + STONE = UROLOGICAL EMERGENCY │
├──────────────────────────────────────────────────────────┤
│ 1. IV FLUIDS + RESUSCITATION │
│ 2. IV ANTIBIOTICS (broad-spectrum, Gram-negative cover) │
│ 3. URGENT DECOMPRESSION: │
│ - Nephrostomy (percutaneous) OR │
│ - Ureteric stent (retrograde) │
│ 4. Stone treatment LATER (once infection cleared) │
│ │
│ DO NOT ATTEMPT PRIMARY STONE REMOVAL │
│ THIS PATIENT CAN DIE │
└──────────────────────────────────────────────────────────┘
Uncomplicated Stone - Acute Management
| Component | Details |
|---|---|
| Analgesia | NSAIDs (diclofenac 75mg IM/PR) first-line; Opioids second-line |
| Antiemetic | Ondansetron, metoclopramide |
| Hydration | Oral or IV; no evidence forced fluids help passage |
| Alpha-blocker | Tamsulosin 400mcg OD (MET for 5-10mm distal stones) |
Stone Size and Management
| Size | Location | Approach |
|---|---|---|
| <5mm | Any | Conservative; 95% pass spontaneously |
| 5-10mm | Distal ureter | MET with tamsulosin; 50-70% pass |
| >0mm | Ureter | Usually needs intervention |
| Any size | With sepsis/AKI | Emergency drainage first |
Interventional Options
| Procedure | Indication | Notes |
|---|---|---|
| Shockwave Lithotripsy (ESWL) | Renal stones <2cm | Non-invasive; may need multiple sessions |
| Ureteroscopy (URS) | Ureteric stones, most efficient | >0% stone-free rate |
| PCNL | Large renal stones (>cm), staghorn | Percutaneous approach |
| Open surgery | Rare, complex cases |
Acute
- Severe pain
- Acute kidney injury (if bilateral or single kidney)
- Sepsis (infected obstruction)
- Forniceal rupture
Chronic
- Chronic kidney disease (recurrent obstruction)
- Recurrent UTIs
- Stone recurrence (50% at 5 years)
Of Intervention
- Ureteric injury (ureteroscopy)
- Steinstrasse (stone fragments blocking after ESWL)
- Haemorrhage (PCNL)
- Infection
Passage Rates by Size
| Stone Size | Spontaneous Passage Rate |
|---|---|
| <5mm | 80-95% |
| 5-10mm | 30-50% (higher with MET) |
| >0mm | <20% |
Recurrence
- 50% recurrence at 5 years
- 75% recurrence at 10 years (without prevention)
- Metabolic workup and prevention can reduce by 50%
Prevention Strategies
| Strategy | Recommendation |
|---|---|
| Fluid intake | >2.5L/day; target urine volume >L |
| Diet | Reduce sodium, moderate protein, normal calcium |
| Citrate | Potassium citrate if low urinary citrate |
| Thiazides | If hypercalciuria (reduce Ca excretion) |
| Allopurinol | If hyperuricosuria or uric acid stones |
Key Guidelines
- NICE NG118: Renal and Ureteric Stones (2019)
- EAU Guidelines on Urolithiasis (2024)
- AUA/Endourological Society Guideline on Stones
Key Evidence
Medical Expulsive Therapy (SUSPEND Trial, 2015)
- RCT: No benefit for tamsulosin in stones <10mm
- But subsequent meta-analyses suggest benefit for 5-10mm distal stones
Fluid Intake
- Increased fluid intake reduces recurrence by 50%
- Target urine output >2L/day
What Are Kidney Stones?
Kidney stones are hard mineral deposits that form in your kidneys when your urine becomes concentrated. They can travel down the tube connecting your kidney to your bladder (ureter), causing severe pain.
What Are the Symptoms?
- Severe pain in your back or side that may move to your lower abdomen and groin
- Pain that comes in waves and fluctuates in intensity
- Blood in your urine (pink, red, or brown)
- Nausea and vomiting
- Needing to urinate frequently
How Are They Treated?
Small stones (<5mm):
- Often pass on their own with plenty of fluids and painkillers
- Medication (tamsulosin) may help the stone pass
Larger stones:
- May need procedures to break up or remove the stone
- Shockwave lithotripsy (sound waves break up the stone)
- Ureteroscopy (camera and laser to break up stone)
When to Seek Emergency Care
Call 999 or go to A&E if you have:
- Fever with kidney stone pain (suggests infection)
- Unable to pass urine
- Uncontrollable pain
- Confusion or feeling very unwell
Preventing Future Stones
- Drink plenty of water (aim for pale yellow urine)
- Reduce salt intake
- Moderate protein intake
- Keep any stones for analysis
Primary Guidelines
- NICE. Renal and ureteric stones: assessment and management (NG118). 2019. nice.org.uk/guidance/ng118
- EAU Guidelines on Urolithiasis. 2024.
Key Studies
- Pickard R, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial (SUSPEND). Lancet. 2015;386(9991):341-349. PMID: 25998582
- Borghi L, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996. PMID: 8558671